Aclaris Therapeutics
Hugh Davis is a seasoned leader in the biotechnology and pharmaceutical industries, currently serving as President and Chief Operating Officer at Aclaris Therapeutics, Inc. since November 2024. Prior to this role, Davis was the Chief Business and Development Officer and President of Biosion USA, Inc. at Biosion, Inc., where innovative therapeutics for oncology and immunological diseases were developed. Davis's previous experience includes serving as Chief Business Officer at Frontage Laboratories, Inc., and various leadership positions at Janssen BioTherapeutics and Johnson & Johnson, focusing on biologics development and clinical pharmacology. Davis holds a Ph.D. and a Master of Science in Biochemistry from Villanova University, completed in 1985 and 1983, respectively.
This person is not in any teams
Aclaris Therapeutics
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options.